PBMs

Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.
DIRs: PBMs Pay Less Each Year While Prices Go UpPBMs have a business model where they pay less even while prices go up.
Diabetic patients challenge insulin makersIn the latest flap over the high cost of drugs, diabetes patients filed a class-action lawsuit against insulin makers.
Value-based care takes over J.P. Morgan Healthcare Conference 2017Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.
Battling DIR FeesThe profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions.
Every pharmacist has them — and so does every teacherWhat do pharmacists and teachers — and an awful lot of other people — have in common?
Is Express Scripts ‘slamming’ pharmacy customers?Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager Express Scripts.
Explore three pathways to fast-growing pharmacy nicheThere are more ways than one to run a specialty pharmacy — and success can be found with any of them.
Remember When: Pharmacists overwhelmingly support Reagan re-election bidThe more things change, the more more they remain the same.
Survey finds stakeholders lack understanding of biosimilarsIt is important to look at how the introduction of biosimilars in the United States may affect your business and your stakeholders and plan for those changes accordingly, according to a new report.